Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(0)(D) immune globulin intravenous administration for immune thrombocytopenic purpura.
about
Advances in Diagnosis and Treatments for Immune ThrombocytopeniaRhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME)Immune thrombocytopeniaComparison of the effects of antibody-coated liposomes, IVIG, and anti-RBC immunotherapy in a murine model of passive chronic immune thrombocytopenia.Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac) in chronic immune thrombocytopenic purpura.Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpuraInvestigation of whether the acute hemolysis associated with Rh(o)(D) immune globulin intravenous (human) administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion reaction model.Anti-RhD immunoglobulin in the treatment of immune thrombocytopeniaDrug-induced hematologic syndromesPathophysiology and therapeutic options in primary immune thrombocytopenia.Immune thrombocytopenia: no longer 'idiopathic'.[Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)].Management of children and adolescents with primary immune thrombocytopenia: controversies and solutions.Comparison of anti-D immunoglobulin, methylprednisolone, or intravenous immunoglobulin therapy in newly diagnosed pediatric immune thrombocytopenic purpura.Management of immune thrombocytopenic purpura: an update.Rozrolimupab, a first-in-class recombinant monoclonal antibody product for primary immune thrombocytopaenia.Anti-D immunoglobulin therapy for pediatric ITP: before and after the FDA's black box warning.Clinical practice: immune thrombocytopenia in paediatrics.How we use WinRho in patients with idiopathic thrombocytopenic purpura.High dose Intravenous Anti-D Immune Globulin is More Effective and Safe in Indian Paediatric Patients of Immune Thrombocytopenic Purpura.State of the art - how I manage immune thrombocytopenia.WinRho and disseminated intravascular coagulopathy.Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti-D immunoglobulin: more questions than answers.Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn.Hypothesis: hemolytic transfusion reactions represent an alternative type of anaphylaxisAdverse effects of transfusion.Chemical treatment of anti-D results in improved efficacy for the inhibition of Fcgamma receptor-mediated phagocytosis.Critical updates in the 7th edition of the American Society for Apheresis guidelines.Management of immune thrombocytopenia: Korean experts recommendation in 2017.
P2860
Q26738630-F4F206CE-6726-4E09-B1BA-3E5ECEE4ECEAQ26824798-FB154C45-21BD-46EC-858E-9F6D9EE86119Q26830918-6EBB35AF-F5AB-4871-BB7F-239D9283D12FQ33373425-3765D096-8C6E-4E0A-B24C-F831E8CA0737Q33375988-F424E01F-560E-4D2F-8042-6CB446A2978BQ33380732-8FD07724-0F47-4217-A4D3-DB2971B19973Q33383303-3B138EF8-66FF-4712-818C-FD18A285FA57Q33385974-DBF4767E-398A-4F18-B282-265222B8E3D6Q33387312-025578C5-1680-4367-9300-CD5681D4D37CQ33393732-503C407B-B00F-4DF4-9375-DBF2157DE5A0Q33395624-9F18E49E-6656-42F3-B8E8-F86123062951Q33400018-F6E78A9F-4032-4937-9383-CAD4220EAB7BQ33402387-2A077DD2-2EAE-4CF2-8E3B-880D236E4E9FQ33403179-F06AEACF-FBDF-47D2-93F9-7C650B8D7146Q33403726-361B5CCC-6E54-4325-9867-0239945C207EQ33407831-30810BDD-9225-4C86-B466-DEEACF57E00DQ33408781-0E0C7AE5-BD4F-4D81-9F73-724896342F9BQ33412475-0A5BFC8A-3043-47B6-A87A-824D6EA6705AQ33423797-DAA63855-07CC-457D-AD3A-1E9A5BCBD5B5Q33439415-EFEA7B53-AD53-4AE4-8B95-1905D0EFFF32Q33440145-09845B6A-20D6-4804-975A-6E5C22C29B4EQ34451234-879F2B80-9526-4E78-ADED-891E088AC3FDQ36903911-684B68CD-45F6-4F21-A94A-4614AB8E1A81Q37252443-FCBCCDDD-F9DA-4BA6-8C1A-573F8496757DQ37284681-05253CCD-42B4-407F-B3D5-42461151EA5FQ38287593-E4B6021D-0F78-4AB2-A415-B5A46469F536Q40090644-58EBECA1-382A-48CC-B21D-EA2FF8739384Q48217985-74F7C34A-6A64-4FAF-90D1-6AA617CF8139Q49624514-1B259CFF-48B5-4679-A1B1-97F6C62ACDDC
P2860
Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(0)(D) immune globulin intravenous administration for immune thrombocytopenic purpura.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Disseminated intravascular coa ...... mune thrombocytopenic purpura.
@ast
Disseminated intravascular coa ...... mune thrombocytopenic purpura.
@en
type
label
Disseminated intravascular coa ...... mune thrombocytopenic purpura.
@ast
Disseminated intravascular coa ...... mune thrombocytopenic purpura.
@en
prefLabel
Disseminated intravascular coa ...... mune thrombocytopenic purpura.
@ast
Disseminated intravascular coa ...... mune thrombocytopenic purpura.
@en
P1433
P1476
Disseminated intravascular coa ...... mune thrombocytopenic purpura.
@en
P2093
Ann Reed Gaines
P304
P356
10.1182/BLOOD-2004-11-4303
P407
P577
2005-05-05T00:00:00Z